Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02756767 · ClinicalTrials.gov registry record
Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 75
- Enrollment target
NCT02756767 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 75 participants.
The verdict
NCT02756767 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
The goals of this study are to assess the feasibility of weekly administration of site specific patient reported assessments using an electronic platform and to explore the correlation between patient reported outcomes as well as known dosimetric prognostic factors in patients with lung, breast, head and neck, or pelvic malignancies
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-04 |
| Est. Completion | 2021-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02756767
The ClinicalTrials.gov registry entry for NCT02756767 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT02756767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02756767 about?
NCT02756767 is a clinical study titled "Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology". The goals of this study are to assess the feasibility of weekly administration of site specific patient reported assessments using an electronic platform and to explore the correlation between patient reported outcomes as well as known dosimetric prognostic factors in patients with lung, breast, hea...
What is the current status of trial NCT02756767?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2016-04. Estimated completion is 2021-04.
What interventions are being tested in trial NCT02756767?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT02756767?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.